Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Opinion in Molecular Therapeutics|April 4, 2008
The therapeutic potential of antisense-mediated exon skippingGert-Jan van Ommen, Judith van Deutekom, Annemieke Aartsma-Rus
Handbook of Clinical Neurology|April 30, 2013
Innovating therapies for muscle diseasesAnnemieke Aartsma-Rus, Gert-Jan Van Ommen, Jean-Claude Kaplan
Human Mutation|January 22, 2009
Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutationsAnnemieke Aartsma-Rus, Ivo Fokkema, Jan Verschuuren, et al.
Neuromuscular Disorders : NMD|March 24, 2010
A 3 months mild functional test regime does not affect disease parameters in young mdx miceMaaike van Putten, Christa de Winter, Willeke van Roon-Mom, et al.
Nucleic Acids Research|September 21, 2010
mRNA degradation controls differentiation state-dependent differences in transcript and splice variant abundancePeter A C 't Hoen, Michael Hirsch, Emile J de Meijer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 29, 2011
Cell-type specific regulation of myostatin signalingDwi U Kemaladewi, David J J de Gorter, Annemieke Aartsma-Rus, et al.
European Journal of Human Genetics : EJHG|February 11, 2010
Therapeutic exon skipping for dysferlinopathies?Annemieke Aartsma-Rus, Kavita H K Singh, Ivo F A C Fokkema, et al.
Briefings in Bioinformatics|October 26, 2007
Biobanking for EuropeMartin Yuille, Gert-Jan van Ommen, Christian Bréchot, et al.
Molecular Therapy. Nucleic Acids|April 3, 2014
Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I ReceptorDwi U Kemaladewi, Svitlana Pasteuning, Joke W van der Meulen, et al.
The Journal of Molecular Diagnostics : JMD|July 4, 2020
Improved Diagnosis of Rare Disease Patients through Systematic Detection of Runs of HomozygosityLeslie Matalonga, Steven Laurie, Anastasios Papakonstantinou, et al.
Pageof 3